Join the club for FREE to access the whole archive and other member benefits.

Generous donations propel next phase of mouse rejuvenation research

Support from Didier Coeurnelle enables groundbreaking longevity studies to advance

01-Oct-2024

Key points from article :

The Longevity Escape Velocity Foundation (LEVF) has received two major donations from Didier Coeurnelle, a long-time advocate for longevity research. The first donation is for 200,000 euros (about $220,000), with a second donation of up to 200,000 euros depending on matching contributions from other donors during October. These funds will support critical pre-study trials ahead of the next phase of LEVF's Robust Mouse Rejuvenation (RMR) project.

RMR1, the initial phase of the study, has been running since early 2023, testing combinations of up to four life-extension treatments on middle-aged mice. The upcoming RMR2 phase will expand to six treatments, aiming to significantly extend both healthspan and lifespan. Caitlin Lewis, LEVF’s Director of Project Pipeline & Strategy, emphasized that these donations will allow for groundbreaking studies that could push longevity interventions into mainstream healthcare.

Didier Coeurnelle highlighted the transformative potential of the RMR studies, stating that the work has the power to change public perceptions of ageing treatments. He urged others to join in funding this crucial research, especially during Longevity Month, which begins October 1st. Aubrey de Grey, LEVF’s President and CSO, praised Coeurnelle's continued support and emphasized the importance of expanding research to target the underlying processes of ageing.







Mentioned in this article:

Click on resource name for more details.

Aubrey de Grey

President and Chief Science Officer at Longevity Escape Velocity (LEV) Foundation

Caitlin Lewis

Director of Project Pipeline & Strategy as LEV Foundation

Didier Coeurnelle

IEET Advisory Board member and a leading European spokesperson in the radical life extension movement

LEV Foundation

Identifying genuinely effective treatments to prevent and reverse human age-related disease

Topics mentioned on this page:
Ageing Research, Investments
Generous donations propel next phase of mouse rejuvenation research